Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Truvada and Raltegravir for HIV Post-exposure Prophylaxis
NCT01214759Phase 4Completed
- Sponsor
- UTHealth Houston
- Start
- May 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by UTHealth Houston. Primary endpoint: Number of Participants Who Were HIV Positive at 6 Months. Started May 2011; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01214759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01214759.